financetom
Business
financetom
/
Business
/
Update: Constellation Brands' Fiscal Q4 Non-GAAP Earnings, Net Sales Beat Gets Bullish Thumbs-up From D.A. Davidson
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Constellation Brands' Fiscal Q4 Non-GAAP Earnings, Net Sales Beat Gets Bullish Thumbs-up From D.A. Davidson
Apr 12, 2024 2:03 AM

04:36 AM EDT, 04/12/2024 (MT Newswires) -- (Updates with analyst comments in the first and last five paragraphs.)

Constellation Brands' ( STZ ) free cash flow growth will be driven by steady market share gains in its beer business and margin expansion from low-end wine divestitures, according to a note from D.A. Davidson late Thursday following the company's fiscal Q4 results.

The company reported fiscal Q4 non-GAAP earnings Thursday of $2.26 per diluted share, compared with $1.98 a year earlier.

Analysts surveyed by Capital IQ expected $2.10.

Net sales for the quarter ended Feb. 29 was $2.14 billion, compared with $2 billion a year earlier.

Analysts surveyed by Capital IQ expected $2.10 billion.

For full-year fiscal 2025, the company expects non-GAAP EPS of $13.50 to $13.80. Analysts surveyed by Capital IQ are expecting $13.43.

In the high-end beer market, import beers are among the fastest growing categories, and Constellation's two largest import brands, Corona and Modelo, are driving more than 80% of all US high-end import sales growth, the D.A. Davidson note said, citing market research firm IRI. Constellation will likely "sustain" beer sales growth in the 7% to 9% range over the medium term.

Constellation's exit from the lower end of the price spectrum in the wine business left the remaining portfolio "better-positioned at the higher end," Senior Research Analyst Eli Sanders said in the note.

Given that higher price points typically bring higher margins, Sanders expects the company to continue expanding its operating margins over the next few years. "Growth in the US alcoholic beverage industry, today, is driven by higher-end price points as consumers increasingly look to 'trade-up,' and STZ is positioned squarely to capitalize on this trend."

Sanders also said Constellation will likely limit mergers and acquisition activity after a period of "mixed success," which will free up capital to return to shareholders.

The analyst increased his 12-month price target on the shares to $309, from the previous $276 per share. STZ was up less than 1% in Friday's premarket activity, to about $270, at last look.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Monopar Therapeutics Says Early Data Validate Potential Cancer Treatment; Shares Jump
Monopar Therapeutics Says Early Data Validate Potential Cancer Treatment; Shares Jump
Sep 12, 2024
08:58 AM EDT, 09/12/2024 (MT Newswires) -- Monopar Therapeutics ( MNPR ) shares rose more than 105% in Thursday's premarket activity after the company said early data from an ongoing phase 1 imaging and dosimetry trial confirmed MNPR-101-Zr's ability to target cancer tumors. The drug is a monoclonal antibody that targets triple-negative breast, colorectal, bladder, ovarian, gastric, and pancreatic cancers,...
Manitex International to Go Private in $223 Million Tadano Merger
Manitex International to Go Private in $223 Million Tadano Merger
Sep 12, 2024
08:58 AM EDT, 09/12/2024 (MT Newswires) -- Manitex International ( MNTX ) said Thursday it has agreed to be bought by Tadano in an all-cash deal valued at $223 million, or $5.80 per share. Upon the completion of the deal, which is expected in Q1 2025, Manitex ( MNTX ) stock will no longer trade publicly, the company said. ...
Altus Power Adds Two Solar Projects in Colorado
Altus Power Adds Two Solar Projects in Colorado
Sep 12, 2024
08:56 AM EDT, 09/12/2024 (MT Newswires) -- Altus Power ( AMPS ) said Thursday that it has added two operational solar projects in Colorado with a combined capacity of 2.5 megawatts. Shares of the company were up more than 2% in recent Thursday premarket activity. Price: 3.3900, Change: +0.08, Percent Change: +2.42 ...
Kazia Therapeutics Executes Deal With QIMR Berghofer Medical to Obtain Intellectual Property License
Kazia Therapeutics Executes Deal With QIMR Berghofer Medical to Obtain Intellectual Property License
Sep 12, 2024
08:54 AM EDT, 09/12/2024 (MT Newswires) -- Kazia Therapeutics ( KZIA ) said Thursday it has executed a deal with QIMR Berghofer Medical Research Institute, an Australian cancer research center, to receive a license for certain intellectual property to develop any drugs or product candidates within the PI3K inhibitor class in combination with immunotherapy or PARP inhibitors. Financial terms weren't...
Copyright 2023-2026 - www.financetom.com All Rights Reserved